These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Sentinel lymph node biopsy in melanoma patients with clinically negative regional lymph nodes--one institution's experience. Nowecki ZI, Rutkowski P, Nasierowska-Guttmejer A, Ruka W. Melanoma Res; 2003 Feb; 13(1):35-43. PubMed ID: 12569283 [Abstract] [Full Text] [Related]
4. Lymphoscintigraphy and intraoperative gamma probe-directed sentinel lymph node mapping in patients with malignant melanoma. Liu SH, Chang WC, Kao PF, Lo YF, Yang CH, Tsai CC, Tzen KY. J Formos Med Assoc; 2004 Jan; 103(1):41-6. PubMed ID: 15026857 [Abstract] [Full Text] [Related]
5. Intraoperative Fluorescence Imaging for Sentinel Lymph Node Detection: Prospective Clinical Trial to Compare the Usefulness of Indocyanine Green vs Technetium Tc 99m for Identification of Sentinel Lymph Nodes. Stoffels I, Dissemond J, Pöppel T, Schadendorf D, Klode J. JAMA Surg; 2015 Jul; 150(7):617-23. PubMed ID: 26017057 [Abstract] [Full Text] [Related]
6. Sentinel lymph node excision and PET-CT in the initial stage of malignant melanoma: a retrospective analysis of 61 patients with malignant melanoma in American Joint Committee on Cancer stages I and II. Klode J, Dissemond J, Grabbe S, Hillen U, Poeppel T, Boeing C. Dermatol Surg; 2010 Apr; 36(4):439-45. PubMed ID: 20187901 [Abstract] [Full Text] [Related]
9. Sentinel lymph-node biopsy for melanoma of the trunk and extremities: the McGill experience. Tremblay F, Louffi A, Shibata H, Meterissian S. Can J Surg; 2001 Dec; 44(6):428-31. PubMed ID: 11764875 [Abstract] [Full Text] [Related]
15. Identification of the sentinel lymph node in patients with malignant melanoma: what are the reasons for mistakes? Vidal-Sicart S, Pons F, Puig S, Ortega M, Vilalta A, Martín F, Rull R, Palou JM, Castel T. Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):362-6. PubMed ID: 12634963 [Abstract] [Full Text] [Related]
17. Sentinel lymph node status is the most important prognostic factor for thick (> or = 4 mm) melanomas. Gutzmer R, Satzger I, Thoms KM, Völker B, Mitteldorf C, Kapp A, Bertsch HP, Kretschmer L. J Dtsch Dermatol Ges; 2008 Mar; 6(3):198-203. PubMed ID: 18093216 [Abstract] [Full Text] [Related]
18. Reliability and accuracy of sentinel node biopsy in cutaneous malignant melanoma. Carcoforo P, Soliani G, Bergossi L, Basaglia E, Virgili AR, Pagani W, Pozza E, Feggi LM. Tumori; 2002 Mar; 88(3):S14-6. PubMed ID: 12365371 [Abstract] [Full Text] [Related]
19. Implications of lymphatic drainage to unusual sentinel lymph node sites in patients with primary cutaneous melanoma. Sumner WE, Ross MI, Mansfield PF, Lee JE, Prieto VG, Schacherer CW, Gershenwald JE. Cancer; 2002 Jul 15; 95(2):354-60. PubMed ID: 12124836 [Abstract] [Full Text] [Related]
20. Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma. Han D, Zager JS, Shyr Y, Chen H, Berry LD, Iyengar S, Djulbegovic M, Weber JL, Marzban SS, Sondak VK, Messina JL, Vetto JT, White RL, Pockaj B, Mozzillo N, Charney KJ, Avisar E, Krouse R, Kashani-Sabet M, Leong SP. J Clin Oncol; 2013 Dec 10; 31(35):4387-93. PubMed ID: 24190111 [Abstract] [Full Text] [Related] Page: [Next] [New Search]